Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Banimmo SA | BANI | Apr 18, 2024 | 3.42 | +1.18 |
Banque Nationale de Belgique | BNB | Apr 18, 2024 | 473.00 | -1.66 |
Barco NV | BAR | Apr 18, 2024 | 15.20 | +2.36 |
Basilix | BAS | Apr 18, 2024 | 13.60 | 0.00 |
Beaulieu Av Certificates | BEAB | Apr 18, 2024 | 1.19 | 0.00 |
Befimmo SA | BEFB | Apr 18, 2024 | 46.10 | 0.00 |
Bel20 | BEL20 | Apr 18, 2024 | 3 826.58 | +0.84 |
Belreca - Belgian Resources and Capital Company | BELR | Apr 18, 2024 | 7.50 | 0.00 |
Beluga NV | BELU | Apr 18, 2024 | 2.00 | 0.00 |
Belysse Group N.V. | BELYS | Apr 18, 2024 | 0.84 | 0.00 |
Biocartis Group NV | BCART | Apr 18, 2024 | 0.29 | 0.00 |
Biosenic | BIOS | Apr 18, 2024 | 0.02 | +0.99 |
Biotalys | BTLS | Apr 18, 2024 | 3.15 | +0.32 |
Boeing | BOEI | Apr 18, 2024 | 224.00 | 0.00 |
Bone Therapeutics S.A. | BOTHE | Apr 18, 2024 | 0.29 | 0.00 |
Bpost S.A. / N.V | BPOST | Apr 18, 2024 | 3.62 | +1.40 |
Brederode S.A. | BREB | Apr 18, 2024 | 109.20 | +0.18 |
Campine nv | CAMB | Apr 18, 2024 | 70.50 | 0.00 |
Candela Invest | CAND | Apr 18, 2024 | 2.90 | 0.00 |
Care Property Invest NV/SA | CPINV | Apr 18, 2024 | 13.14 | +1.08 |
Celyad Oncology SA | CYAD | Apr 18, 2024 | 0.33 | -2.54 |
Cenergy Holdings | CENER | Apr 18, 2024 | 6.93 | -0.86 |
Chevron | CHTEX | Apr 18, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Apr 18, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Apr 18, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Apr 18, 2024 | 62.25 | +0.32 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Apr 18, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Apr 18, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Apr 18, 2024 | 40.98 | +0.69 |
Compagnie du Bois Sauvage S.A. | COMB | Apr 18, 2024 | 249.00 | +1.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.